XML 32 R21.htm IDEA: XBRL DOCUMENT
v3.25.1

Earnings (Loss) Per Share | 9 Months Ended
--- | ---
Mar. 31, 2025
Earnings Per Share [Abstract] |
Earnings (Loss) Per Share | Earnings (Loss) Per Share Basic earnings (loss) per common share is computed by dividing net earnings (loss) available to the common shareholders by the weighted-average number of shares of common stock outstanding during the period. Diluted earnings (loss) per common share is computed by dividing the diluted earnings (loss) available to the common shareholders by the weighted-average number of shares of common stock and potentially dilutive shares of common stock outstanding during the period. The dilutive effect of equity awards is calculated based on the average stock price for each fiscal period, using the treasury stock method. For the three months ended March 31, 2025, as the Company was in a net loss position, there were no dilutive shares. For the nine months ended March 31, 2025, diluted shares outstanding include the dilutive effect of the potential shares of Coherent Common Stock issuable from performance and restricted shares. For the three and nine months ended March 31, 2024, as the Company was in a net loss position, there were no dilutive shares. Potentially dilutive shares whose effect would have been anti-dilutive are excluded from the computation of diluted earnings (loss) per common share. For the three months ended March 31, 2025, diluted loss per share excluded the potentially dilutive effect of the performance and restricted shares, calculated based on the average stock price for each fiscal period, using the treasury stock method, as well as the shares of Coherent Common Stock issuable upon conversion of the Series B Convertible Preferred Stock (under the If-Converted method), as their effects were anti-dilutive. For the nine months ended March 31, 2025, diluted earnings per share excludes the potentially dilutive effect of the shares of Coherent Common Stock issuable upon conversion of the Series B Convertible Preferred Stock (under the If-Converted method), as their effects were anti-dilutive. For the three and nine months ended March 31, 2024, diluted loss per share excluded the potentially dilutive effect of the performance and restricted shares, calculated based on the average stock price for each fiscal period, using the treasury stock method, as well as the shares of Coherent Common Stock issuable upon conversion of the Series B Convertible Preferred Stock (under the If-Converted method), as their effects were anti-dilutive. The following is a reconciliation of the numerators and denominators of the basic and diluted earnings (loss) per share computations (000, except per share data):
| Three Months Ended March 31, |  | Nine Months Ended March 31,
| 2025 |  | 2024 |  | 2025 |  | 2024
Numerator |  |  |  |  |  |  |
Net earnings (loss) attributable to Coherent Corp. | $ | 15,711 |  |  | $ | (13,187) |  |  | $ | 144,983 |  |  | $ | (107,712) |
Deduct Series B dividends and deemed dividends | (32,693) |  |  | (31,193) |  |  | (96,788) |  |  | (91,946) |
Basic earnings (loss) available to common shareholders | $ | (16,982) |  |  | $ | (44,380) |  |  | $ | 48,195 |  |  | $ | (199,658) |
Diluted earnings (loss) available to common shareholders | $ | (16,982) |  |  | $ | (44,380) |  |  | $ | 48,195 |  |  | $ | (199,658) |
Denominator |  |  |  |  |  |  |
Weighted average shares | 155,175 |  |  | 152,138 |  |  | 154,518 |  |  | 151,341 |
Effect of dilutive securities: |  |  |  |  |  |  |
Common stock equivalents | — |  |  | — |  |  | 4,702 |  |  | — |
Diluted weighted average common shares | 155,175 |  |  | 152,138 |  |  | 159,220 |  |  | 151,341 |
Basic earnings (loss) per common share | $ | (0.11) |  |  | $ | (0.29) |  |  | $ | 0.31 |  |  | $ | (1.32) |
Diluted earnings (loss) per common share | $ | (0.11) |  |  | $ | (0.29) |  |  | $ | 0.30 |  |  | $ | (1.32) |
The following table presents potential shares of common stock excluded from the calculation of diluted net earnings (loss) per share, as their effect would have been anti-dilutive (000):
| Three Months Ended March 31, |  | Nine Months Ended March 31,
| 2025 |  | 2024 |  | 2025 |  | 2024
Common stock equivalents | 290 |  |  | 3,546 |  |  | 100 |  |  | 2,613 |
Series B Convertible Preferred Stock | 29,281 |  |  | 27,862 |  |  | 28,921 |  |  | 27,518 |
Total anti-dilutive shares | 29,571 |  |  | 31,408 |  |  | 29,021 |  |  | 30,131 |

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/260/tableOfContent Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-3 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration